Across
4. Deadpool
7. Yamanaka
9. Autotomy
12. Oncogenomics
13. Totipotent
14. Notch
​
Down
1. Hydra
2. Trachea
3. Prostate
5. Ear
6. Breast
8. Neurogenesis
10. DoctorWho
11. Liver
Neurogenesis by Sjoerd Morris
Getting Personal by Ben McCullough
Tailoring Treatment by Rosie Jackson
Athena Swan by Alice Milne
Day in the Life by Nishani Jeyapalan and Elizabeth Stephen
Adult neurogenesis: mechanisms and functional significance.
S.M Braun and S Jessberger
Development 2014 141:1983-1986
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus.
H. van Praag, G. Kempermann and F.H Gage
Nature Neuroscience 1999 2:266 - 270
http://www.nature.com/neuro/journal/v2/n3/full/nn0399_266.html
More Information
Neuroprosthetics Profile by Cassandra Smith and Riona Mc Ardle
Historic Profile by Kelli Gallacher
The Developmental Capacity of Nuclei taken from Intestinal Epithelium Cells of Feeding Tadpoles.
J. B. Gurdon
Development 1962 10: 622-640
Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells.
S. Yamanaka
Cell Stem Cell 2007 1:39-49
Eatwell for the Elderly by Nuno Mendonca
Pluripotency and nuclear reprogramming.
S. Yamanaka
Philospical Transactions B Royal Society 2008 363:2079-2087
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2610180/
Environmental enrichment and voluntary exercise massively increase neurogenesis in the adult hippocampus via dissociable pathways.
A.K. Olson, B.D. Eadie, C. Ernst and B.R. Christie
Hippocampus 2006 16:250-60
http://onlinelibrary.wiley.com/doi/10.1002/hipo.20157/abstract
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
J.E. Malberg, A.J. Eisch, E.J. Nestler and R.S. Duman
The Journal of Neuroscience 2000 20:9104:9110
Mechanisms and Functional Implications of Adult Neurogenesis.
C. Zhao, W. Deng and F.H Gage
Cell 2008 132:645-660
Clone your tumour to fight your cancer.
L. Geddes
New Scientist 2015
https://www.newscientist.com/article/mg22530142-400-clone-your-tumour-to-fight-your-cancer/
Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial.
A. Vora, N. Gouldan, R. Wade, C. Mitchell, J. Hancock, R. Hough, C. Rowntree and S. Richards
Lancet Oncology 2013 14:199-209
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(12)70600-9/abstract
Clinical Significance of Minimal Residual Disease in Childhood Acute Lymphoblastic Leukemia.
H. Cavé et al
New England Journal of Medicine 1998 339:591-598
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.
J.M. van Dongen et al
Lancet 1998 352:1731-1738
http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(98)04058-6/abstract